These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 19951531)

  • 1. [The regulation effect of liposomal transfection of antisense oligonucleotide on the alpha-globin in patients with severe beta-thalassemia].
    Liu RR; Ma J; Chen P; Mo WN; Lin WX; Lai YR
    Zhonghua Xue Ye Xue Za Zhi; 2009 Jun; 30(6):385-9. PubMed ID: 19951531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of liposomal transfection of antisense oligodeoxynucleotide on alpha-globin gene expression and proliferation of K562 cells].
    Liu RR; Lai YR; Ma J
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Oct; 15(5):1065-9. PubMed ID: 17956692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversal of aberrant splicing of beta-thalassemia allele by antisense RNA in vitro and in vivo.
    Zeng Y; Gu X; Chen Y; Gong L; Ren Z; Huang S
    Chin Med J (Engl); 1999 Feb; 112(2):107-11. PubMed ID: 11593572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alpha globin gene duplications in beta thalassemia patients with intact beta globin gene.
    Faà V; Masala M; Cao A; Rosatelli MC
    Blood Cells Mol Dis; 2010 Mar; 44(3):156-8. PubMed ID: 20117028
    [No Abstract]   [Full Text] [Related]  

  • 5. [Update on RNA splicing repair: applications to beta thalassemia and other perspectives].
    Labie D; Kaplan JC
    Med Sci (Paris); 2010 Jan; 26(1):38-41. PubMed ID: 20132773
    [No Abstract]   [Full Text] [Related]  

  • 6. Efficacy of Rapamycin as Inducer of Hb F in Primary Erythroid Cultures from Sickle Cell Disease and β-Thalassemia Patients.
    Pecoraro A; Troia A; Calzolari R; Scazzone C; Rigano P; Martorana A; Sacco M; Maggio A; Di Marzo R
    Hemoglobin; 2015; 39(4):225-9. PubMed ID: 26016899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between AHSP gene expression, β/α globin mRNA ratio, and clinical severity of the β-thalassemia patients.
    Ranjbaran R; Okhovat MA; Mobarhanfard A; Aboualizadeh F; Abbasi M; Moezzi L; Golafshan HA; Behzad-Behbahani A; Bagheri M; Sharifzadeh S
    Ann Clin Lab Sci; 2014; 44(2):189-93. PubMed ID: 24795058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. alpha-Thalassemia-like globin gene expression by primitive erythrocytes derived from human embryonic stem cells.
    Honig GR; Lu SJ; Feng Q; Vida LN; Lee BS; Lanza R
    Hemoglobin; 2010 Jan; 34(2):145-50. PubMed ID: 20353349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular basis of thalassemia intermedia in Iran.
    Akbari MT; Izadi P; Izadyar M; Kyriacou K; Kleanthous M
    Hemoglobin; 2008; 32(5):462-70. PubMed ID: 18932071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Repair of the splicing defect of thalassemic allele beta IVS-2-654 C-->T in cultured human erythroid cells by antisense RNA].
    Gu X; Gong L; Zhang W
    Zhonghua Yi Xue Za Zhi; 1997 Nov; 77(11):815-8. PubMed ID: 9772473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful correction of the human Cooley's anemia beta-thalassemia major phenotype using a lentiviral vector flanked by the chicken hypersensitive site 4 chromatin insulator.
    Malik P; Arumugam PI; Yee JK; Puthenveetil G
    Ann N Y Acad Sci; 2005; 1054():238-49. PubMed ID: 16339671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Understanding globin regulation in beta-thalassemia: it's as simple as alpha, beta, gamma, delta.
    Bank A
    J Clin Invest; 2005 Jun; 115(6):1470-3. PubMed ID: 15931385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequency of alpha-globin gene triplications and their interaction with beta-thalassemia mutations.
    Giordano PC; Bakker-Verwij M; Harteveld CL
    Hemoglobin; 2009; 33(2):124-31. PubMed ID: 19373588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. α-Globin as a molecular target in the treatment of β-thalassemia.
    Mettananda S; Gibbons RJ; Higgs DR
    Blood; 2015 Jun; 125(24):3694-701. PubMed ID: 25869286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathophysiology of beta thalassemia--a guide to molecular therapies.
    Thein SL
    Hematology Am Soc Hematol Educ Program; 2005; ():31-7. PubMed ID: 16304356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Controlling alpha-globin: a review of alpha-globin expression and its impact on beta-thalassemia.
    Voon HP; Vadolas J
    Haematologica; 2008 Dec; 93(12):1868-76. PubMed ID: 18768527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemoglobin gene therapy for β-thalassemia.
    Bank A
    Hematol Oncol Clin North Am; 2010 Dec; 24(6):1187-201. PubMed ID: 21075288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular therapies in beta-thalassaemia.
    Quek L; Thein SL
    Br J Haematol; 2007 Feb; 136(3):353-65. PubMed ID: 17129232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Restoration of the balanced alpha/beta-globin gene expression in beta654-thalassemia mice using combined RNAi and antisense RNA approach.
    Xie SY; Ren ZR; Zhang JZ; Guo XB; Wang QX; Wang S; Lin D; Gong XL; Li W; Huang SZ; Zeng F; Zeng YT
    Hum Mol Genet; 2007 Nov; 16(21):2616-25. PubMed ID: 17716993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Understanding α-globin gene regulation and implications for the treatment of β-thalassemia.
    Mettananda S; Gibbons RJ; Higgs DR
    Ann N Y Acad Sci; 2016 Mar; 1368(1):16-24. PubMed ID: 26695885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.